(Q36136038)

12 August 2017

Azlocillin compared with carbenicillin in the treatment of bronchopulmonary infection due to Pseudomonas aeruginosa in cystic fibrosis (English)

1 reference

12 August 2017

0 references

1 reference

Pseudomonas aeruginosa

1 reference

Penketh A

1

1 reference

12 August 2017

Hodson ME

series ordinal

2

1 reference

12 August 2017

Gaya H

series ordinal

3

1 reference

12 August 2017

Batten JC

series ordinal

4

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 April 1984

1 reference

12 August 2017

1 reference

12 August 2017

39

1 reference

12 August 2017

299-304

1 reference

12 August 2017

4

1 reference

The pathogenesis and treatment of pulmonary infections in patients with cystic fibrosis

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=459787

Pseudomonas infection, allergy, and cystic fibrosis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=459787

Chemotherapy against Pseudomonas aeruginosa in cystic fibrosis. A study of carbenicillin, azlocillin or piperacillin in combination with tobramycin

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=459787

Activities of New Beta-Lactam Antibiotics Against Isolates of Pseudomonas aeruginosa from Patients with Cystic Fibrosis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=459787

Cystic fibrosis in adults. 75 cases and a review of 232 cases in the literature

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=459787

Azlocillin--a new penicillin against Pseudomonas aeruginosa and other gram-negative bacteria

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=459787

Azlocillin and mezlocillin: two new semisynthetic acylureido-penicillins (author's transl)

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=459787

Pseudomonas infections of the lung treated with azlocillin. Microbiology, pharmacokinetics, clinic

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=459787

Activity of Azlocillin and Mezlocillin Against Gram-Negative Organisms: Comparison with Other Penicillins

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=459787

Pseudomonas colonization in cystic fibrosis. A study of 160 patients

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=459787

Pharmacokinetics of azlocillin in children with cystic fibrosis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=459787

New cause of penicillin treatment failure

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=459787

Bacteremia in patients with cystic fibrosis

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=459787

Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period

23 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/6426075

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Azlocillin in the treatment of serious infection with Pseudomonas aeruginosa

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/6426075

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Ticarcillin compared with carbenicillin in the treatment of exacerbations of bronchopulmonary infection in cystic fibrosis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/6426075

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/THX.39.4.299

1 reference

12 August 2017

1 reference

12 August 2017

1 reference